Amsterdam Molecular Therapeutics Holding N.V. - Ownership and Business Overview

Life ScienceCompany

Amsterdam Molecular Therapeutics Holding N.V. Ownership

Who owns Amsterdam Molecular Therapeutics Holding N.V.?

Amsterdam Molecular Therapeutics Holding N.V. is owned by uniQure N.V.. It was acquired on February 17, 2012.

Amsterdam Molecular Therapeutics Holding N.V. Business Overview

Where is Amsterdam Molecular Therapeutics Holding N.V. headquartered?

Amsterdam Molecular Therapeutics Holding N.V. is headquartered in Amsterdam, Netherlands.

What sector is Amsterdam Molecular Therapeutics Holding N.V. in?

Amsterdam Molecular Therapeutics Holding N.V. is a life science company.

When was Amsterdam Molecular Therapeutics Holding N.V. founded?

Amsterdam Molecular Therapeutics Holding N.V. was founded in 1998.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Amsterdam Molecular Therapeutics (AMT) Holding N.V.

P.O.Box 22506,
Amsterdam, 1100 DA
Netherlands,
312 056 67394
www.amtbiopharma.com

Amsterdam Molecular Therapeutics engages in the development of human gene based therapies. AMT has a product pipeline of gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson’s disease and SanfilippoB.


Company Summary

SECTOR

Life Science

Established

1998

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Amsterdam Molecular Therapeutics Holding N.V.

Life Science Companies , Netherlands Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Netherlands Companies

Largest Netherlands Companies , Acquisitive Netherlands Companies , Recently Acquired Netherlands Companies , Recently Sold Netherlands Companies , Private Netherlands Companies , Public Netherlands Companies , Acquired Netherlands Companies , PE Backed Netherlands Companies
Mergr

Product

Company

Legal